Skip to search boxSkip to navigationSkip to main content

Highly-efficient morphogens for guided angiogenesis

  • Maria Verdenelli(Author)
Student thesis:
Student thesis
Doctoral Thesis

About the thesis

Coronary artery disease and stroke are leading causes of mortality in Europe, resulting in a<br/>loss of function of the affected tissue. One of the challenges is to restore the myocardium<br/>tissue functionality using growth-factors mimicking peptides to stimulate the development<br/>of pre-existing blood vessels to enhance tissue regeneration and ensure tissue viability. In<br/>this research, hyperbranched peptides based on poly (ɛ-lysine) (i.e. dendrons) of different<br/>branching generations (Gx) were used as protein scaffolds to present, at their uppermost<br/>branching generation, peptide analogues for key growth factors such as the Angiopoietin-1<br/>(Ang-1), the Vascular Endothelial growth factor (VEGF) or the Platelet Derived growth<br/>factor (PDGF-BB). The resulting dendritic angiogenic peptides have been designed<br/>specifically to target myocardial ischemic tissue starting from a molecular root [diphenilalanine<br/>(FF)] capable of being retained for longer times within the target tissue by<br/>interacting with the extracellular matrix (ECM) through hydrophobic interactions and<br/>being decorated with the specific angiogenic bioactive peptide analogues capable of<br/>inducing a precise biological response in targeting cells.<br/>Synthesis of the dendritic angiogenic peptides was performed using an established solid<br/>phase method by a manual method and characterised by analytical HPLC, Mass<br/>Spectrometry and FT-IR. The angiogenic potential of dendritic angiogenic peptides has<br/>been evaluated by a 2D in vitro model where the human umbilical vein endothelial cells<br/>(HUVECs) were spiked with the soluble linear and dendritic analogues resulting in an<br/>endothelial sprouting. Successively, dendritic angiogenic peptides have been used as<br/>functionalisation molecules for collagen type I engineered as either injectable biomaterials<br/>(beads) or cardiac patches (scaffolds). The potential of these novel synthesised molecules<br/>in inducing angiogenesis in vitro when covalently grafted to the biomaterial surfaces also<br/>showed an angiogenic potential demonstrating that the bioactivity is not confined to their<br/>soluble form. However, their bioactivity in both soluble and grafted form was shown to<br/>depend on the molecular branching of the dendron and relative availability of the bioactive<br/>sequences. Indeed, the present study for the first time unveils a novel biomaterial approach<br/>to stimulate angiogenesis through nano-structured biomaterials and emphasise the need for<br/>a finely spaced presentation of the relevant peptide sequence to obtain established<br/>endothelial sprouting.

Thesis information

Thesis Award Date

01/2018

Qualification Level

Doctoral Thesis

Original Language

English

Thesis Managed By

Supervisors

Matteo Santin (Supervisor)

Awarding Institution